摘要
微小RNA(miRNA)参与多种重要的细胞生物学过程,还参与包括肝细胞癌(HCC)在内的多种疾病的发生与发展。近年来研究发现miR-32在多种肿瘤组织中表达异常,miR-32在HCC中表达上调,扮演了“致癌基因”的角色,参与调控体内HCC细胞的细胞周期、凋亡及侵袭转移等多个病理生理过程,并有望成为HCC治疗的新靶点。
MicroRNAs (miRNA)play an important role in a variety of cellular biology processes,and participate in the occurrence and development of a variety of diseases including hepatocellular carcinoma (HCC).In recent years,miR-32 has been shown to be aberrantly expressed in many tumor tissues.miR-32 is up-regulated in HCC and plays an oncogene role in regulating the cell cycle,apoptosis,invasion,metastasis and so on.MiR-32 maybe a potential target for HCC therapy.
作者
姜晓佳
李胜棉
Jiang Xiaojia Li Shengmian(Department of Gastroentero- logy, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China)
出处
《国际肿瘤学杂志》
CAS
2017年第1期75-77,共3页
Journal of International Oncology